Direct-Acting Antivirals in Chronic Hepatitis C Genotype 4 Infection in Community Care Setting

BACKGROUND: Limited data exists comparing the safety, tolerability, and efficacy of direct-acting antivirals (DAAs) in patients with chronic hepatitis C genotype 4 (HCV GT-4) in the community practice setting. We aim to evaluate the treatment response of DAAs in these patients. METHODS: All the HCV...

Descripción completa

Detalles Bibliográficos
Autores principales: Gayam, Vijay, Khalid, Mazin, Mandal, Amrendra Kumar, Hussain, Muhammad Rajib, Mukhtar, Osama, Gill, Arshpal, Garlapati, Pavani, Shrestha, Binav, Guss, Debra, Sherigar, Jagannath, Mansour, Mohammed, Mohanty, Smruti
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916637/
https://www.ncbi.nlm.nih.gov/pubmed/29707080
http://dx.doi.org/10.14740/gr999w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5916637/
https://www.ncbi.nlm.nih.gov/pubmed/29707080
http://dx.doi.org/10.14740/gr999w

Ejemplares similares